InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Morgan Adam. Officer active across 2 companies, notably HERON THERAPEUTICS, INC. /DE/. In total, 10 disclosures have been published. Split: 3 buys · 0 sell. Total volume traded: €7.5m. History available since 22 February 2023. The latest transaction was disclosed on 30 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Morgan Adam is a declarant linked to HERON THERAPEUTICS, INC. /DE/ and Alimera Sciences INC, where he is a Director. The block shows 10 filings in total, and across the sampled recent filings the buy volume is EUR 7527221 between 2023-02-24 and 2026-02-03, with the modal transaction nature listed as Attribution.